LOLLINI, PIER LUIGI
LOLLINI, PIER LUIGI
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di Ia fascia
Lollini P.-L.; Pier L Lollini; Pier-Luigi Lollini; Pierluigi Lollini; P. LOLLINI; P.L. LOLLINI
CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1-targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscape
2024 Pasello M.; Laginestra M.A.; Manara M.C.; Landuzzi L.; Ruzzi F.; Maioli M.; Pellegrini E.; De Feo A.; Lollini P.-L.; Scotlandi K.
Engagement of CD99 activates distinct programs in Ewing sarcoma and macrophages
2024 Manara, Maria Cristina; Manferdini, Cristina; Cristalli, Camilla; Carrabotta, Marianna; Santi, Spartaco; De Feo, Alessandra; Caldoni, Giulia; Pasello, Michela; Landuzzi, Lorena; Lollini, Pier-Luigi; Salamanna, Francesca; Dominici, Sabrina; Fiori, Valentina; Magnani, Mauro; Lisignoli, Gina; Scotlandi, Katia
Functional evaluation of circulating anti-cancer antibodies with a 3D tumor cell growth inhibition assay
2024 Ruzzi F.; Semprini M.S.; Scalambra L.; Angelicola S.; Cappello C.; Pittino O.M.; Nanni P.; Palladini A.; Lollini P.L.
IL-1 Family Members in Bone Sarcomas
2024 Lorena Landuzzi, Francesca Ruzzi, Evelin Pellegrini, Pier-Luigi Lollini, Katia Scotlandi, Maria Cristina Manara
Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes?
2024 Francesca Ruzzi, Chiara Cappello, Maria Sofia Semprini, Laura Scalambra, Stefania Angelicola, Olga Maria Pittino, Lorena Landuzzi, Arianna Palladini, Patrizia Nanni, Pier-Luigi Lollini
Programmable Release of Chemotherapeutics from Ferrocene-Based Injectable Hydrogels Slows Melanoma Growth
2024 Rothe R.; Xu Y.; Wodtke J.; Brandt F.; Meister S.; Laube M.; Lollini P.-L.; Zhang Y.; Pietzsch J.; Hauser S.
IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience
2023 Setola, Elisabetta; Benini, S; Righi, A; Gamberi, G; Carretta, E; Ferrari, C; Avnet, S; Palmerini, E; Magagnoli, G; Gambarotti, M; Lollini, P L; Cesari, M; Cocchi, S; Paioli, A; Longhi, A; Scotlandi, K; Laginestra, M A; Donati, D M; Baldini, N; Ibrahim, T
Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma
2023 Landuzzi L.; Manara M.C.; Pazzaglia L.; Lollini P.L.; Scotlandi K.
Preclinical activity of ES2B-C001, a human candidate HER-2 virus-like particle (VLP) vaccine, against mammary carcinoma onset and metastasis
2023 Ruzzi, F; Palladini, A; Clemmensen, S; Strobaek, A; Buijs, N; Domeyer, T; Dorosz, J; Soroka, V; Grzadziela, D; Rasmussen, CJ; Nielsen, IB; Soegaard, M; Semprini, MS; Scalambra, L; Angelicola, S; Landuzzi, L; Lollini, PL; Thorn, M
Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research
2023 Lorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini, Katia Scotlandi
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy
2023 Ruzzi F.; Semprini M.S.; Scalambra L.; Palladini A.; Angelicola S.; Cappello C.; Pittino O.M.; Nanni P.; Lollini P.-L.
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
2022 Pasello, Michela; Giudice, Anna Maria; Cristalli, Camilla; Manara, Maria Cristina; Mancarella, Caterina; Parra, Alessandro; Serra, Massimo; Magagnoli, Giovanna; Cidre-Aranaz, Florencia; Grünewald, Thomas G P; Bini, Carla; Lollini, Pier-Luigi; Longhi, Alessandra; Donati, Davide Maria; Scotlandi, Katia
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC
2022 Ruzzi, Francesca; Angelicola, Stefania; Landuzzi, Lorena; Nironi, Elena; Semprini, Maria Sofia; Scalambra, Laura; Altimari, Annalisa; Gruppioni, Elisa; Fiorentino, Michelangelo; Giunchi, Francesca; Ferracin, Manuela; Astolfi, Annalisa; Indio, Valentina; Ardizzoni, Andrea; Gelsomino, Francesco; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
2022 Pasello, Michela; Giudice, Anna Maria; Cristalli, Camilla; Manara, Maria Cristina; Mancarella, Caterina; Parra, Alessandro; Serra, Massimo; Magagnoli, Giovanna; Cidre-Aranaz, Florencia; Grünewald, Thomas G P; Bini, Carla; Lollini, Pier-Luigi; Longhi, Alessandra; Donati, Davide Maria; Scotlandi, Katia
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality
2022 Sorrentino, Carlo; D'Antonio, Luigi; Ciummo, Stefania Livia; Fieni, Cristiano; Landuzzi, Lorena; Ruzzi, Francesca; Vespa, Simone; Lanuti, Paola; Lotti, Lavinia Vittoria; Lollini, Pier Luigi; Di Carlo, Emma
Divergent transcriptional and transforming properties of PAX3-FOXO1 and PAX7-FOXO1 paralogs.
2022 Line MANCEAU, Julien RICHARD ALBERT, Pier-Luigi LOLLINI, Maxim V. C. GREENBERG, Pascale GILARDI-HEBENSTREIT1, Vanessa RIBES
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma
2022 Carrabotta, Marianna; Laginestra, Maria Antonella; Durante, Giorgio; Mancarella, Caterina; Landuzzi, Lorena; Parra, Alessandro; Ruzzi, Francesca; Toracchio, Lisa; De Feo, Alessandra; Giusti, Veronica; Pasello, Michela; Righi, Alberto; Lollini, Pier-Luigi; Palmerini, Emanuela; Donati, Davide Maria; Manara, Maria Cristina; Scotlandi, Katia
Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma
2022 Chiarini, Francesca; Paganelli, Francesca; Balestra, Tommaso; Capanni, Cristina; Fazio, Antonietta; Manara, Maria Cristina; Landuzzi, Lorena; Petrini, Stefania; Evangelisti, Camilla; Lollini, Pier-Luigi; Martelli, Alberto M.; Lattanzi, Giovanna; Scotlandi, Katia
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine
2022 Ruzzi, Francesca; Palladini, Arianna; Clemmensen, Stine; Strøbæk, Anette; Buijs, Nicolaas; Domeyer, Tanja; Dorosz, Jerzy; Soroka, Vladislav; Grzadziela, Dagmara; Rasmussen, Christina Jo; Nielsen, Ida Busch; Soegaard, Max; Semprini, Maria Sofia; Scalambra, Laura; Angelicola, Stefania; Landuzzi, Lorena; Lollini, Pier-Luigi; Thorn, Mette
Targeting CD99 compromises the oncogenic effects of the chimera EWS-FLI1 by inducing re-expression of zyxin and inhibition of Gli1 activity
2022 Balestra, Tommaso; Manara, Maria Cristina; Laginestra, Maria Antonella; Pasello, Michela; De Feo, Alessandra; Bassi, Cristian; Guerzoni, Clara; Landuzzi, Lorena; Lollini, Pier-Luigi; Donati, Davide Maria; Negrini, Massimo; Magnani, Mauro; Scotlandi, Katia
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1-targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscape | Pasello M.; Laginestra M.A.; Manara M.C.; Landuzzi L.; Ruzzi F.; Maioli M.; Pellegrini E.; De Feo... A.; Lollini P.-L.; Scotlandi K. | 2024-01-01 | JOURNAL OF CELL COMMUNICATION AND SIGNALING | - | 1.01 Articolo in rivista | Journal of Cell Communication and Signaling - 2024 - Pasello - CD99 contributes to the EWS FLI1 transcriptome by.pdf |
Engagement of CD99 activates distinct programs in Ewing sarcoma and macrophages | Manara, Maria Cristina; Manferdini, Cristina; Cristalli, Camilla; Carrabotta, Marianna; Santi, Sp...artaco; De Feo, Alessandra; Caldoni, Giulia; Pasello, Michela; Landuzzi, Lorena; Lollini, Pier-Luigi; Salamanna, Francesca; Dominici, Sabrina; Fiori, Valentina; Magnani, Mauro; Lisignoli, Gina; Scotlandi, Katia | 2024-01-01 | CANCER IMMUNOLOGY RESEARCH | - | 1.01 Articolo in rivista | CD99 Mac cir-23-0440 opt.pdf |
Functional evaluation of circulating anti-cancer antibodies with a 3D tumor cell growth inhibition assay | Ruzzi F.; Semprini M.S.; Scalambra L.; Angelicola S.; Cappello C.; Pittino O.M.; Nanni P.; Pallad...ini A.; Lollini P.L. | 2024-01-01 | METHODS IN CELL BIOLOGY | - | 1.01 Articolo in rivista | - |
IL-1 Family Members in Bone Sarcomas | Lorena Landuzzi, Francesca Ruzzi, Evelin Pellegrini, Pier-Luigi Lollini, Katia Scotlandi, Maria C...ristina Manara | 2024-01-01 | CELLS | - | 1.01 Articolo in rivista | IL-1 review Cells 2024.pdf |
Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes? |
Francesca Ruzzi, Chiara Cappello, Maria Sofia Semprini, Laura Scalambra, Stefania Angelicola, Ol...ga Maria Pittino, Lorena Landuzzi, Arianna Palladini, Patrizia Nanni, Pier-Luigi Lollini |
2024-01-01 | CELL COMMUNICATION AND SIGNALING | - | 1.01 Articolo in rivista | Lipid rafts review.pdf |
Programmable Release of Chemotherapeutics from Ferrocene-Based Injectable Hydrogels Slows Melanoma Growth | Rothe R.; Xu Y.; Wodtke J.; Brandt F.; Meister S.; Laube M.; Lollini P.-L.; Zhang Y.; Pietzsch J....; Hauser S. | 2024-01-01 | ADVANCED HEALTHCARE MATERIALS | - | 1.01 Articolo in rivista | - |
IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience | Setola, Elisabetta; Benini, S; Righi, A; Gamberi, G; Carretta, E; Ferrari, C; Avnet, S; Palmerini..., E; Magagnoli, G; Gambarotti, M; Lollini, P L; Cesari, M; Cocchi, S; Paioli, A; Longhi, A; Scotlandi, K; Laginestra, M A; Donati, D M; Baldini, N; Ibrahim, T | 2023-01-01 | BMC CANCER | - | 1.01 Articolo in rivista | Setola Chondrosarcomapdf.pdf |
Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma | Landuzzi L.; Manara M.C.; Pazzaglia L.; Lollini P.L.; Scotlandi K. | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | Synovial review 2 cancers-15-03887-v3.pdf |
Preclinical activity of ES2B-C001, a human candidate HER-2 virus-like particle (VLP) vaccine, against mammary carcinoma onset and metastasis | Ruzzi, F; Palladini, A; Clemmensen, S; Strobaek, A; Buijs, N; Domeyer, T; Dorosz, J; Soroka, V; G...rzadziela, D; Rasmussen, CJ; Nielsen, IB; Soegaard, M; Semprini, MS; Scalambra, L; Angelicola, S; Landuzzi, L; Lollini, PL; Thorn, M | 2023-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research | Lorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini, Katia Scotlandi | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | Synovial cancers-15-00588.pdf |
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy | Ruzzi F.; Semprini M.S.; Scalambra L.; Palladini A.; Angelicola S.; Cappello C.; Pittino O.M.; Na...nni P.; Lollini P.-L. | 2023-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | VLP Review ijms-24-12963-v2.pdf |
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis | Pasello, Michela; Giudice, Anna Maria; Cristalli, Camilla; Manara, Maria Cristina; Mancarella, Ca...terina; Parra, Alessandro; Serra, Massimo; Magagnoli, Giovanna; Cidre-Aranaz, Florencia; Grünewald, Thomas G P; Bini, Carla; Lollini, Pier-Luigi; Longhi, Alessandra; Donati, Davide Maria; Scotlandi, Katia | 2022-01-01 | CELLULAR ONCOLOGY | - | 1.01 Articolo in rivista | ABCA6 Cellular Oncology.pdf; 13402_2022_713_MOESM9_ESM.zip |
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC | Ruzzi, Francesca; Angelicola, Stefania; Landuzzi, Lorena; Nironi, Elena; Semprini, Maria Sofia; S...calambra, Laura; Altimari, Annalisa; Gruppioni, Elisa; Fiorentino, Michelangelo; Giunchi, Francesca; Ferracin, Manuela; Astolfi, Annalisa; Indio, Valentina; Ardizzoni, Andrea; Gelsomino, Francesco; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna | 2022-01-01 | TRANSLATIONAL LUNG CANCER RESEARCH | - | 1.01 Articolo in rivista | ADK-VR2 TLCR.pdf; tlcr-11-11-2216-coif.zip |
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis | Pasello, Michela; Giudice, Anna Maria; Cristalli, Camilla; Manara, Maria Cristina; Mancarella, Ca...terina; Parra, Alessandro; Serra, Massimo; Magagnoli, Giovanna; Cidre-Aranaz, Florencia; Grünewald, Thomas G P; Bini, Carla; Lollini, Pier-Luigi; Longhi, Alessandra; Donati, Davide Maria; Scotlandi, Katia | 2022-01-01 | CELLULAR ONCOLOGY | - | 1.01 Articolo in rivista | s13402-022-00735-z.pdf |
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality | Sorrentino, Carlo; D'Antonio, Luigi; Ciummo, Stefania Livia; Fieni, Cristiano; Landuzzi, Lorena; ...Ruzzi, Francesca; Vespa, Simone; Lanuti, Paola; Lotti, Lavinia Vittoria; Lollini, Pier Luigi; Di Carlo, Emma | 2022-01-01 | JOURNAL OF HEMATOLOGY & ONCOLOGY | - | 1.01 Articolo in rivista | IL-30 Di Carlo J Hematol Oncol_compressed.pdf; 13045_2022_1357_MOESM1_ESM.docx; 13045_2022_1357_MOESM2_ESM.docx |
Divergent transcriptional and transforming properties of PAX3-FOXO1 and PAX7-FOXO1 paralogs. | Line MANCEAU, Julien RICHARD ALBERT, Pier-Luigi LOLLINI, Maxim V. C. GREENBERG, Pascale GILARDI-H...EBENSTREIT1, Vanessa RIBES | 2022-01-01 | PLOS GENETICS | - | 1.01 Articolo in rivista | Ribes PAX-FOXO PLoS Genetics 2022.pdf; 1-s2.0-S1553838920300968-main.pdf |
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma | Carrabotta, Marianna; Laginestra, Maria Antonella; Durante, Giorgio; Mancarella, Caterina; Landuz...zi, Lorena; Parra, Alessandro; Ruzzi, Francesca; Toracchio, Lisa; De Feo, Alessandra; Giusti, Veronica; Pasello, Michela; Righi, Alberto; Lollini, Pier-Luigi; Palmerini, Emanuela; Donati, Davide Maria; Manara, Maria Cristina; Scotlandi, Katia | 2022-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | CIC-DUX4 Cancer Res 2022.pdf; can-21-1222_supplementary_data_supp1-9.pdf; can-21-1222_supplementary_methods_and_figures_supp1-13.pdf |
Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma | Chiarini, Francesca; Paganelli, Francesca; Balestra, Tommaso; Capanni, Cristina; Fazio, Antoniett...a; Manara, Maria Cristina; Landuzzi, Lorena; Petrini, Stefania; Evangelisti, Camilla; Lollini, Pier-Luigi; Martelli, Alberto M.; Lattanzi, Giovanna; Scotlandi, Katia | 2022-01-01 | CELL DEATH & DISEASE | - | 1.01 Articolo in rivista | Lamin Cell Death Dis.pdf; 41419_2022_4729_MOESM1_ESM.pdf |
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine | Ruzzi, Francesca; Palladini, Arianna; Clemmensen, Stine; Strøbæk, Anette; Buijs, Nicolaas; Domeye...r, Tanja; Dorosz, Jerzy; Soroka, Vladislav; Grzadziela, Dagmara; Rasmussen, Christina Jo; Nielsen, Ida Busch; Soegaard, Max; Semprini, Maria Sofia; Scalambra, Laura; Angelicola, Stefania; Landuzzi, Lorena; Lollini, Pier-Luigi; Thorn, Mette | 2022-01-01 | BIOMEDICINES | - | 1.01 Articolo in rivista | biomedicines-10-02654-v2.pdf; biomedicines-10-02654-s001.zip |
Targeting CD99 compromises the oncogenic effects of the chimera EWS-FLI1 by inducing re-expression of zyxin and inhibition of Gli1 activity | Balestra, Tommaso; Manara, Maria Cristina; Laginestra, Maria Antonella; Pasello, Michela; De Feo,... Alessandra; Bassi, Cristian; Guerzoni, Clara; Landuzzi, Lorena; Lollini, Pier-Luigi; Donati, Davide Maria; Negrini, Massimo; Magnani, Mauro; Scotlandi, Katia | 2022-01-01 | MOLECULAR CANCER THERAPEUTICS | - | 1.01 Articolo in rivista | - |